Zydus Lifesci.

48
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE010B01027
  • NSEID: ZYDUSLIFE
  • BSEID: 532321
INR
931.45
-4.3 (-0.46%)
BSENSE

Dec 05

BSE+NSE Vol: 9.03 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
23,241.00
19,547.00
17,237.00
15,109.00
15,102.00
14,253.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
23,241.00
19,547.00
17,237.00
15,109.00
15,102.00
14,253.00
Expenditure (Ex Depriciation)
Stock Adjustments
-184.00
-250.00
238.00
-362.00
-149.00
-93.00
Raw Materials Consumed
6,522.00
6,478.00
6,072.00
5,907.00
5,359.00
5,013.00
Power & Fuel Cost
375.00
384.00
361.00
315.00
249.00
268.00
Employee Cost
3,680.00
3,137.00
2,765.00
2,434.00
2,490.00
2,395.00
Operating Expenses
605.00
528.00
472.00
497.00
543.00
526.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
2,207.00
1,658.00
1,557.00
1,373.00
1,388.00
1,352.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1,351.00
1,037.00
770.00
767.00
972.00
973.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
16,183.00
14,163.00
13,377.00
11,769.00
11,761.00
11,469.00
Operating Profit (PBDIT) excl Other Income
7,058.00
5,384.00
3,859.00
3,340.00
3,341.00
2,783.00
Other Income
269.00
284.00
186.00
224.00
37.00
113.00
Operating Profit (PBDIT)
7,328.00
5,668.00
4,046.00
3,565.00
3,378.00
2,897.00
Interest
165.00
81.00
129.00
127.00
163.00
341.00
Profit before Depriciation and Tax
7,162.00
5,587.00
3,916.00
3,438.00
3,214.00
2,555.00
Depreciation
915.00
764.00
722.00
713.00
724.00
696.00
Profit Before Taxation & Exceptional Items
6,246.00
4,823.00
3,193.00
2,725.00
2,489.00
1,859.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
6,026.00
4,808.00
2,589.00
2,838.00
2,284.00
1,495.00
Provision for Tax
1,411.00
977.00
587.00
511.00
147.00
319.00
Profit After Tax
4,614.00
3,831.00
2,001.00
2,326.00
2,137.00
1,175.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
20,369.00
17,189.00
15,495.00
11,384.00
8,612.00
8,333.00
Profit Available for appropriations
24,894.00
21,026.00
17,460.00
13,625.00
10,746.00
9,510.00
Appropriations
24,894.00
21,026.00
17,460.00
13,625.00
10,746.00
9,510.00
Equity Dividend (%)
1,100.00%
300.00%
600.00%
250.00%
350.00%
350.00%
Earnings Per Share
44.97
38.14
19.30
43.83
20.84
11.49
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 18.90% vs 13.40% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 31.09% vs 39.49% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 104.31% vs -37.49% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 20.45% vs 91.39% in Mar 2024

Compare Profit and Loss Results of Zydus Lifesci.
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
23,241.00
22,707.00
534.00
2.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
23,241.00
22,707.00
534.00
2.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-184.00
-257.00
73.00
28.40%
Raw Materials Consumed
6,522.00
7,100.00
-578.00
-8.14%
Power & Fuel Cost
375.00
479.00
-104.00
-21.71%
Employee Cost
3,680.00
3,964.00
-284.00
-7.16%
Operating Expenses
605.00
1,982.00
-1,377.00
-69.48%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2,207.00
1,417.00
790.00
55.75%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1,351.00
486.00
865.00
177.98%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
16,183.00
17,430.00
-1,247.00
-7.15%
Operating Profit (PBDIT) excl Other Income
7,058.00
5,277.00
1,781.00
33.75%
Other Income
269.00
201.00
68.00
33.83%
Operating Profit (PBDIT)
7,328.00
5,479.00
1,849.00
33.75%
Interest
165.00
294.00
-129.00
-43.88%
Profit before Depriciation and Tax
7,162.00
5,184.00
1,978.00
38.16%
Depreciation
915.00
1,169.00
-254.00
-21.73%
Profit Before Taxation & Exceptional Items
6,246.00
4,014.00
2,232.00
55.61%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6,026.00
4,015.00
2,011.00
50.09%
Provision for Tax
1,411.00
708.00
703.00
99.29%
Profit After Tax
4,614.00
3,306.00
1,308.00
39.56%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
20,369.00
11,183.00
9,186.00
82.14%
Profit Available for appropriations
24,894.00
14,464.00
10,430.00
72.11%
Appropriations
24,894.00
14,464.00
10,430.00
72.11%
Equity Dividend (%)
1100%
600%
500.00
Earnings Per Share
44.97
71.95
-26.98
-37.50%
Profit And Loss - Net Sales
Net Sales 23,241.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.90% vs 13.40% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7,058.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 31.09% vs 39.49% in Mar 2024

Profit And Loss - Interest
Interest 165.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 104.31% vs -37.49% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4,614.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.45% vs 91.39% in Mar 2024